Nachrichten

US judge approves Bayer's $7.25 billion cancer settlement

DW

A US judge on Friday approved German chemical giant Bayer's $7.25 billion (€6.60 billion) settlement of lawsuits claiming its Roundup weedkiller causes cancer. Judge Timothy Boyer in the US state of Missouri ruled that the agreement was "fair, reasonable, and adequate." The decision could help Bayer end years of costly legal battles over Roundup, which the company acquired when it bought US weedkiller producer Monsanto in 2018. "The court's final approval is a decisive milestone in the company's strategy to mitigate the risks of both pending and future Roundup litigation," Bayer CEO Bill Anderson said. The agreement covers tens of thousands of people who say they developed non-Hodgkin lymphoma, a type of blood cancer, after using Roundup.

Vollstaendiges Veytics-Briefing lesen

Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.